Hong Kong’s coronavirus testing drive tests negative for popularity
By Shibani Mahtani and Ryan Ho Kilpatrick,
Washington Post
| 09. 01. 2020
HONG KONG — Borrowing from mainland China's pandemic playbook, Hong Kong officials began a drive Tuesday to mass-test residents for the novel coronavirus, hoping for near-universal participation to flaunt the city's civic sensibilities and patriotism.
Authorities readied more than 100 sample collection centers and thousands of volunteer medical staff to work them. State media ran stories praising the city's government while touting the ability of officials in mainland China to run millions of tests a day. Fliers distributed to households publicized the seven-day exercise that could be extended for up to two weeks.
But there were few takers.
By 4 p.m. on Tuesday, eight hours after the program began, 82,000 people had come forward — slightly over 1 percent of the population and far below the daily average required to reach the government’s target of 5 million. Most testing centers were quiet; health workers in protective gear and face shields sat around idle.
Although it was just the first day of the campaign, the outcome highlighted the yawning trust deficit between Hong Kong leaders and residents, rather than showcasing...
Related Articles
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...
By Jared Whitlock, Endpoints News | 07.15.2025
Patient groups face a harder and unpredictable path going state-by-state to boost screening for rare but treatable conditions after the Trump administration disbanded a federal advisory committee on newborn screening.
In April, the Advisory Committee on Heritable Disorders in Newborns...
By Ben Fidler and Ned Pagliarulo, Biopharma Dive | 07.21.2025
One month ago, a 51-year-old man treated in a clinical trial with an experimental gene therapy became dangerously sick. The developer of that treatment, Sarepta Therapeutics, informed the Food and Drug Administration his case could be life-threatening.
The man died...
By Pat Duggins, Alabama Public Radio | 06.27.2025
PAT DUGGINS-- If I were to say, ‘man, have you seen the price of eggs these days?’ You're probably thinking, Oh, he's talking about inflation and the price of groceries and how it became an issue in the presidential race...